Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Helms

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
JACC. Clinical Electrophysiology|July 4, 2021
Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMRChristopher M Kramer, John P DiMarco, Paul Kolm, et al.
JACC. Advances|June 28, 2024
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular CardiomyopathyAlessio Gasperetti, Richard Carrick, Alexandros Protonotarios, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Research Square|February 6, 2026
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathiesDaria Kramarenko, Poeya Haydarlou, George Powell, et al.
Heart Rhythm|April 29, 2026
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variantsAlessio Gasperetti, Barbara Bauce, Alexandros Protonotarios, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
JACC. Clinical Electrophysiology|July 4, 2021
Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMRChristopher M Kramer, John P DiMarco, Paul Kolm, et al.
JACC. Advances|June 28, 2024
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular CardiomyopathyAlessio Gasperetti, Richard Carrick, Alexandros Protonotarios, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Research Square|February 6, 2026
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathiesDaria Kramarenko, Poeya Haydarlou, George Powell, et al.
Heart Rhythm|April 29, 2026
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variantsAlessio Gasperetti, Barbara Bauce, Alexandros Protonotarios, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Pageof 3